Growing Burden of Chronic Diseases Globally

Global healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Globally, a considerable increase in the burden of chronic diseases pressuring countries to adopt effective and efficient distribution of healthcare products. Commonly prevailing chronic diseases include heart attacks and strokes, cancer such as breast and colon, diabetes, epilepsy and seizures, obesity, and oral health issues. 

Browse the full report description of “Healthcare Distribution Market Size, Share & Trends Analysis Report by Type (Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Services, and Medical Device Distribution Services), and by End-User (Retail Pharmacies, Hospital Pharmacies, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/healthcare-distribution-market

Key Statistics

• According to the International Agency for Research and Cancer (IARC), in 2022, over 1.9 million cases of colorectal cancer were diagnosed. It is the 3rd most common cancer type around the globe. 

• As per the World Health Organization (WHO), around 1.5 million fatalities are directly attributed to diabetes every year. Currently, more than 422 million people around the globe have diabetes.

• From the same source, the prevalence of overweight including obesity among children and adolescents aged between 5 to 19 years has risen from just 8.0% in 1990 to 20.0% in 2023.

As a result, several government organizations are increasing their spending significantly for distributing pharmaceuticals and medical devices across the globe. According to the American Cancer Society, global spending on cancer medicines and related supportive care increased from $96 billion in 2017 to $133 billion in 2022. The growth rate of cancer medicines expenditure greatly exceeds that of newly diagnosed cancer cases; from 2017 through 2022, cancer medicines expenditure per incident cancer case was about 2-fold to 8-fold higher than the overall per capita health expenditure.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Type

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- McKesson Corp., Cardinal Health, Smith Drug Co., AmerisourceBergen Corp . (Cencora, Inc.), and Henry Schein, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Healthcare Distribution Market Report Segment

By Type

Pharmaceutical Product Distribution Services

• OTC Drugs/ Vitamins
• Generic Drugs
• Brand Name/ Innovator Drugs

• Biopharmaceutical Product Distribution Services

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Blood & Blood Products
• Others (Cellular & Gene Therapy, Stem Cells, Tissues & Tissue Products)

• Medical Device Distribution Services

By End-User

• Retail Pharmacies
• Hospital Pharmacies
• Others (Clinical Laboratories, Physician Offices, Home Care Settings, Online Pharmacies)

Global Healthcare Distribution Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• The Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/healthcare-distribution-market